Antihypertensive Treatment in Acute Cerebral Hemorrhage "ATACH"
Active, not recruiting
Phase 1 ResultsSummary of Purpose
The purpose of this trial is to evaluate the safety and effectiveness of lowering blood pressure using nicardipine in persons with acute hypertension associated with intracerebral hemorrhage.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 18 September 2012.
| 1 Jul 2005 | 21 Dec 2006 | 1 Jul 2015 | 1 Jul 2015 | 1 Sep 2012 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Non-Randomized
- Masking: Open Label
- Purpose: Treatment
- Endpoint: Safety Study
- Intervention: Single Group Assignment
Contacts
-
Jill M. Novitzke, RN Zeenat Qureshi Stroke Research Center University of Minnesota Department of Neurology 12-131 PWB 516 Delaware St SE Minneapolis, MN 55455 PH 612/626-9302 FX 612/625-7950 Email: novit001@umn.edu
novit001@umn.edu
View Trial Locations
Recruitment
- Enrollment: 60
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 12 locations, 1 country
Principal Investigator
- Adnan I. Qureshi, MD
University of Minnesota - Clinical and Translational Science Institute
